The Developing Country NGO Delegation to the Global Fund Board represents the non-governmental organizations/community-based organizations/faith-based organizations response to HIV/AIDS, TB and malaria in the Global South at the Board of the Global Fund to Fight AIDS, Tuberculosis and Malaria.

The report analyses trends and patterns in 2015 for 35 neglected diseases - including TB - across 142 product areas including drugs, vaccines, diagnostics, microbicides and vector control products.

TB advocates urge PEPFAR to provide immediate access to the LAM test for TB diagnosis in HIV-positive people with advanced immunosuppression.

TB advocates appeal to Sequella to act in the interest of public health and provide open access to all existing sutezolid data.

The guide provides an overview of the different tests and strategies for detecting TB and makes recommendations for how activists and clinicians can contribute to improved TB diagnosis.

TB advocates reiterate the important role the Ministry of Health must play in facilitating access to delamanid for Peruvians with multidrug-resistant TB.

Health groups call on the Indian Government to incorporate the life-saving TB drug delamanid into the Revised National TB Control Programme.

While deal marks a critical step in the fight against TB, health groups warn that the deal lacks safeguards that would ensure worldwide affordability.

TB advocates encourage Danaher, a holdings company that recently acquired Cepheid, to prioritize the continued development of critical Cepheid products for TB.

Advocates urge Prime Minister Modi to take immediate action to save a young woman, dying of XDR-TB and to roll out life-saving innovations to tackle the growing burden of drug-resistant TB in India.